In-Vitro Fertilization Market to Grow to US$ 725.9 Million by the End of 2022

The rising rate of infertility among men and women in several developing and developed regions has led to the demand for in-vitro fertilization procedures. A growing number of men and women who are infertile due to anatomic factors or chromosomal defects are finding favorable outcomes in IVF as assisted reproductive technologies. A number of improper lifestyle changes also have aggravated the problem of infertility, even after a year of unprotected intercourse between the couples. The growing awareness of male infertility among populations in the Middle East and Africa (MEA) and some parts of Europe has also catalyzed the demand for IVF treatments. In several developed countries, the use of IVF is gaining prominence among fertile couples who are suffering with genetic diseases but do not want to transfer the defects in their offspring. Recent advancements in IVF devices and reagent also augurs well for the market. The rise in medical tourism in some emerging economies is expected to unlock exciting opportunities in the coming years.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12698

The global in-vitro fertilization market is projected to grow from US$529.8 Mn in 2017 to US$725.9 Mn by the end of 2022. The worldwide market is forecast to expand at a CAGR of 6.5% during 2017–2022.

The major regional markets profiled in the report are North America, Latin America, Middle East and Africa, Europe, Asia Pacific excluding Japan (APEJ), and Japan. Of these, the APEJ holds the major revenue of the global market in 2017 and is expected to retain its dominance through the forecast timeline. Rising at a CAGR of 6.7% from 2017 to 2022, the APEJ in-vitro fertilization market will reach a worth US$235.9 Mn by the end of the forecast period. The dominance is attributed to favorable governmental initiatives and a burgeoning medical tourism in several emerging nations. The regional market will further benefit from players looking to capitalize on opportunities from unmet medical needs.

The North America in-vitro fertilization market is projected to rise from US$141.3 Mn in 2017 to US$196.1 Mn by the end of 2022. The regional market is anticipated to rise at an impressive CAGR of 6.8% during 2017 - 2022. Constant advancements made in IVF technologies and growing insurance coverage are key factors accentuating the regional market. Furthermore, the growth is likely to be fueled by rising rate of infertility in the region.

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=12698

Meanwhile, Europe in-vitro fertilization market is projected to lose some 44 BPS from 2017 to 2022. By 2017 end, the global share of the regional market is estimated at 19.9%, vis-à-vis revenue. The MEA market is also estimated to lose 11 BPS in its market share from 2017 through 2022.

On the basis of product type, the report segments the in-vitro fertilization market into equipment, reagents, and others. Among these, the reagents holds the major share in the market. The estimated valuation of the segment is US$ 284.1 Mn in 2017, standing for 53.6% and is projected to rise to US$ 385.9 Mn by 2022 end. This will represent a share of 53.2%, an incremental decline in share. However, the annual growth of the segment in absolute terms is US$ 20.3 Mn, which is larger than all other segments. The segment is anticipated to register a CAGR of 6.3% during the forecast period.

Some of prominent players operating in the market are Thermo Fisher Scientific, Inc., Cook Medical, Merck KGaA, Vitrolife AB, Ovascience, Inc., CooperSurgical, EMD Serono, Inc., Genea Ltd., Rocket Medical PLC, and Fertility Focus Ltd. These players are focused on launching advanced technologies that are likely to substantially improve the outcome of the IVF cycles. This will help them gain a competitive edge over others.

Report Overview @ https://www.transparencymarketresearch.com/in-vitro-fertilization-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.